Our studies in the 4T1 murine model of aggressive/metastatic breast cancer provide direct evidence that tumor cell metabolism (high LDH-A expression) is associated with a “poor prognosis” phenotype, and is mediated through more robust HIF-1α and downstream target responses to hypoxia. This evidence concerns the gene HIF1A and breast carcinoma.